← FDA DRUG APPROVALS

FDA NDA · NDA215352

MYDCOMBI

Sponsor: EYENOVIA

APPLICATION
NDA215352
TYPE
NDA
ORIGINAL APPROVAL
2023-05-05
LATEST ACTION
2023-05-05
ROUTE
OPHTHALMIC
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Discontinued

Products

MYDCOMBI · ReferenceDiscontinued
PHENYLEPHRINE HYDROCHLORIDE 2.5%, TROPICAMIDE 1% · SPRAY, METERED · OPHTHALMIC

Approval history

2023-05-05Type 5 - New Formulation or New Manufacturer · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →